Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €76.40 EUR
Change Today +0.70 / 0.92%
Volume 849.0
As of 5:25 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - eli lilly & co (LLY)

Name (Connections)Board RelationshipsTitleKey Developments
Michael Eskew 66 RelationshipsDirector, Chairman of Audit Committee, Member of Finance Committee and Member of Directors & Corporate Governance CommitteeFair Trade Commission Fines Pfizer Inc., Merck Sharpe & Dohme, Eli Lilly & Co., Glaxosmithkline plc and Otsuka Group
01/15/09
Kathi Seifert 32 RelationshipsDirector, Member of Compensation Committee and Member of Audit CommitteeFederal probe could expand to cover Lilly's top-selling drug
03/10/04
Katherine Baicker Ph.D. 14 RelationshipsDirector, Member of Public Policy & Compliance Committee and Member of Audit CommitteeSEC Probing Polish Operations of Lilly
11/13/03
Jackson Tai 134 RelationshipsDirector, Member of Audit Committee and Member of Finance CommitteeU.S. Securities and Exchange Commission Charges Eli Lilly and Company for Improper Payments its Subsidiaries Made to Foreign Government Officials to Win Millions of Dollars of Business in Russia, Brazil, China and Poland
12/20/12

Compensation Committee* - eli lilly & co (LLY)

Name (Connections)Board RelationshipsTitle
Ralph Alvarez 23 RelationshipsDirector, Member of Science & Technology Committee and Member of Compensation Committee
Karen Horn Ph.D. 106 RelationshipsDirector, Chairman of Compensation Committee and Member of Directors & Corporate Governance Committee
Ellen Marram 179 RelationshipsLead Independent Director, Chairman of Directors & Corporate Governance Committee and Member of Compensation Committee
Kathi Seifert 32 RelationshipsDirector, Member of Compensation Committee and Member of Audit Committee
LLY Compensation vs. Industry
1.5M
466.5K
Chief Executive Officer
1.0M
291.0K
Chief Financial Officer
Share price activity for ELI LILLY & CO (LLY)
52 Week Price Performance
LLY
Industry Average

Corporate Governance Committee* - eli lilly & co (LLY)

Name (Connections)Board RelationshipsTitle
Michael Eskew 66 RelationshipsDirector, Member of Science & Technology Committee and Member of Compensation Committee
Karen Horn Ph.D. 106 RelationshipsDirector, Chairman of Compensation Committee and Member of Directors & Corporate Governance Committee
Ellen Marram 179 RelationshipsLead Independent Director, Chairman of Directors & Corporate Governance Committee and Member of Compensation Committee
LLY and Competitor
Insiders vs. External
Board
13%
87%
Eli Lilly and Company
8%
92%
Amgen Inc.
18%
82%
Bristol-Myers Squibb Company
8%
92%
Medtronic plc
9%
91%
Abbott Laboratories
11%
89%
AbbVie Inc.
Insiders
External Board Members

Executive Committee* - eli lilly & co (LLY)

Name (Connections)Board RelationshipsTitle
Melissa Barnes 0 RelationshipsChief Ethics & Compliance Officer and Senior Vice President of Enterprise Risk Management
Michael Harrington 0 RelationshipsGeneral Counsel and Senior Vice President
Barton Peterson 0 RelationshipsSenior Vice President of Corporate Affairs & Communications and Member of Operations Committee
Management Effectiveness Relative to the Industry
Return on Equity
0.8x
Return on Assets
0.8x
Return on Total Capital
0.8x
TEV/Total Revenue(LTM)
0.8x

Finance Committee* - eli lilly & co (LLY)

Name(Connections)Board RelationshipsTitle
Michael Eskew 66 RelationshipsDirector, Chairman of Audit Committee, Member of Finance Committee and Member of Directors & Corporate Governance Committee
Jackson Tai 134 RelationshipsDirector, Member of Audit Committee and Member of Finance Committee
Debt To Total Capitalization35.5x
It is important for the finance committee to know when to issue debt or equity.

Committee of Directors* - eli lilly & co (LLY)

Name (Board Relationships)/TitleBoard Affiliations
Karen Horn 106 Relationships
Director, Chairman of Compensation Committee and Member of Directors & Corporate Governance Committee
Ellen Marram 179 Relationships
Lead Independent Director, Chairman of Directors & Corporate Governance Committee and Member of Compensation Committee
Michael Eskew 66 Relationships
Director, Chairman of Audit Committee, Member of Finance Committee and Member of Directors & Corporate Governance Committee
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:GR €76.40 EUR +0.70

LLY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $50.69 USD -0.36
AbbVie Inc $69.34 USD +1.26
Amgen Inc $165.54 USD +6.95
Bristol-Myers Squibb Co $64.30 USD -1.68
Medtronic PLC $75.66 USD -0.35
View Industry Companies
 

Industry Analysis

LLY

Industry Average

Valuation LLY Industry Range
Price/Earnings 44.0x
Price/Sales 4.6x
Price/Book 6.0x
Price/Cash Flow 45.7x
TEV/Sales 4.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.